X
XTL Biopharmaceuticals Ltd. (XTLB)
NCM – Real vaqt narxi. Valyuta: USD
2.61
-0.24 (-8.42%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
2.61
-0.24 (-8.42%)
Yopilishda: May 12, 2026, 4:00 PM EDT
XTL Biopharmaceuticals Ltd., biotexnologiya kompaniyasi, Isroilda avtoimmun kasalliklarni davolash uchun farmatsevtika preparatlarini sotib olish va ishlab chiqish bilan shug'ullanadi. Uning yetakchi dori nomzodi hCDR1 bo'lib, u tizimli qizil yug'irichi va Sjögren sindromini davolash uchun II bosqichga tayyor aktivdir. Kompaniya turli ko'rsatmalar uchun hCDR1 tadqiqot, ishlab chiqish va tijoratlashtirish bo'yicha Yeda Research and Development Company Limited bilan litsenziya shartnomasiga ega. Kompaniya ilgari Xenograft Technologies Ltd. nomi bilan tanilgan va 1995 yil iyul oyida XTL Biopharmaceuticals Ltd. nomini o'zgartirgan. XTL Biopharmaceuticals Ltd. 1993 yilda tashkil etilgan va shtab-kvartirasi Isroilning Ramat Gan shahrida joylashgan.
There is no data to display
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 6-K | ea0289561-6k_xtlbio.htm |
| 2026-04-29 | 6-K | ea0288126-6k_xtlbio.htm |
| 2026-03-10 | 6-K | ea0280782-6k_xtlbio.htm |
| 2026-02-27 | 6-K | ea0279045-6k_xtlbio.htm |
| 2026-02-24 | 6-K | ea0278174-6k_xtlbio.htm |
| 2026-02-23 | 6-K | ea0278012-6k_xtlbio.htm |
| 2026-02-17 | 6-K | ea0277362-6k_xtlbio.htm |
| 2026-01-28 | 6-K | ea0274345-6k_xtlbio.htm |
| 2026-01-23 | 6-K | ea0273753-6k_xtlbio.htm |
| 2026-01-13 | 6-K | ea0272708-6k_xtlbio.htm |